Press Releases ReNeuron Group plc

Equities

Market Closed - London S.E. Other stock markets 08:00:01 05/02/2024 pm IST			5-day change	1st Jan Change
3.375 ^GBX	-2.17%		-.--%	-3.57%

26/06	ReNeuron Group plc Announces Change of Registered Office Address	CI
31/05	RENEURON GROUP PLC Announces Termination of John Michael Hawkins as Director	CI

RENEURON ISSUES ADMINISTRATION WARNING	06/02	AQ
Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™	27/11	EQ
ReNeuron : Interim Statement 2023	16/11	PU
ReNeuron : Presentation	08/11	PU
ReNeuron : 24 July 2023 – Notice of Annual General Meeting	24/23/24	PU
ReNeuron : Annual Report 2023	16/23/16	PU
ReNeuron has extended cash runway as it focuses on validating its exosome platform	21/23/21	AQ
ReNeuron : Preliminary results presentation for the year ended 31 March 2022	06/22/06	PU
ReNeuron : Preliminary Results for the year ended 31 March 2022	04/22/04	PU
ReNeuron : Update on the Technology Transfer and Supply Agreement with Fosun Pharma	01/22/01	PU
ReNeuron : Interim Statement 2021	07/21/07	PU
ReNeuron : New CTX-iPSC platform data shows potential in Peripheral Nerve Repair	19/21/19	PU
ReNeuron : Collaboration agreement with UCL	26/21/26	PU
ReNeuron : First subject treated at Oxford Eye Hospital in Phase 2a RP trial	18/21/18	PU
ReNeuron : Further changes in the Board of Directors	18/21/18	PU
ReNeuron : First subject treated at Oxford Eye Hospital	18/21/18	PU
ReNeuron : Regulatory approval for continuation of Phase 2a RP trial	01/21/01	PU
ReNeuron : Annual Report 2021	11/21/11	PU
ReNeuron : Preliminary results presentation for the year ended 31 March 2021	09/21/09	PU
ReNeuron : Preliminary Results for the year ended 31 March 2021	08/21/08	PU

No results for this search